Company / Working Capital per Share
Arcus Biosciences, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.42
FY2025
5-year range
$8.42 / $16.83
FY2021-FY2025
Trend
-19.6%
vs FY2024
Sector context
#60 of 210
Health Care
What the data says
At $8.42, Arcus Biosciences, Inc.'s working capital per share ranks #60 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 9 years, ranging from $3.82 in FY2019 to $89.78 in FY2017.
Based on SEC 10-K filings.
8.42 in FY2025 with a 5-year CAGR of -8.8%.
Declined from $8.88 to $8.42 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -12.0%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Sector benchmark
#60 of 210 in Health CareTop 29% of 210This company $8.42 Sector average $146.86
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 19.6% year-over-year.
- Ranks #60 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2017.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.42 | -19.6% |
| FY2024 | $10.46 | +17.9% |
| FY2023 | $8.88 | -28.1% |
| FY2022 | $12.34 | -26.7% |
| FY2021 | $16.83 | +25.9% |
| FY2020 | $13.37 | +250.4% |
| FY2019 | $3.82 | -93.5% |
| FY2018 | $59.16 | -34.1% |
| FY2017 | $89.78 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026